{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:23:56Z","timestamp":1790065436468,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T00:00:00Z","timestamp":1453766400000},"content-version":"vor","delay-in-days":3039,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Surgery"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/s1015-9584(08)60045-7","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T01:42:51Z","timestamp":1281577371000},"page":"302-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Bacillus Calmette\u2013Gu\u00e9rin and Bladder Cancer"],"prefix":"10.1016","volume":"30","author":[{"given":"Azad H.A.","family":"Razack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S1015-9584(08)60045-7_bib1","author":"Cancer incidence, mortality and prevalence worldwide"},{"key":"10.1016\/S1015-9584(08)60045-7_bib2","first-page":"5","article-title":"Cancer Statistics 2003","volume":"53","author":"Jemal","year":"2003","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/S1015-9584(08)60045-7_bib3","author":"Cancer Research UK"},{"key":"10.1016\/S1015-9584(08)60045-7_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8588(18)30360-5","article-title":"Epidemiology of bladder cancer","volume":"6","author":"Silverman","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"issue":"Suppl 6A","key":"10.1016\/S1015-9584(08)60045-7_bib5","first-page":"4","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2006","journal-title":"Urology"},{"key":"10.1016\/S1015-9584(08)60045-7_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s003450000190","article-title":"Neo-adjuvant chemotherapy in invasive bladder cancer","volume":"19","author":"Sternberg","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0094-0143(05)70229-9","article-title":"The natural history of bladder cancer. Implications for therapy","volume":"27","author":"Lee","year":"2000","journal-title":"Urol Clin North Am"},{"key":"10.1016\/S1015-9584(08)60045-7_bib8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables. A combined analysis of 2596 patients from EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0090-4295(94)90134-1","article-title":"Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer","volume":"43","author":"Hasui","year":"1994","journal-title":"Urology"},{"key":"10.1016\/S1015-9584(08)60045-7_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1040-8428(03)00073-8","article-title":"The new World Health Organisation\/International Society of Urological Pathology (WHO\/ISUP) classification for TA, T1 bladder tumours: is it an improvement?","volume":"47","author":"Epstein","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1309\/0KATYHQBJD5XHQ8J","article-title":"Histologic grading of non-invasive papillary urothelial tumours","volume":"121","author":"Yin","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib12","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1464-410X.2006.06445.x","article-title":"The pathology of bladder cancer: an update on selected issues","volume":"98","author":"Pavone-Macaluso","year":"2006","journal-title":"BJU"},{"key":"10.1016\/S1015-9584(08)60045-7_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00005392-199907000-00018","article-title":"The value of second transurethral resection in evaluating patients with bladder tumours","volume":"162","author":"Herr","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.eururo.2003.12.016","article-title":"A second look TUR in T1 transitional cell carcinoma: why?","volume":"45","author":"Jakse","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0094-0143(05)70240-8","article-title":"An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy","volume":"27","author":"Duque","year":"2000","journal-title":"Urol Clin North Am"},{"key":"10.1016\/S1015-9584(08)60045-7_bib16","series-title":"BCG Vaccine: Tuberculosis-Cancer","first-page":"35","article-title":"The history of BCG","author":"Guerin","year":"1957"},{"key":"10.1016\/S1015-9584(08)60045-7_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/tuld.1999.0206","article-title":"Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree","volume":"79","author":"Oettinger","year":"1999","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/S1015-9584(08)60045-7_bib18","first-page":"97","article-title":"Cancer and tuberculosis","volume":"9","author":"Pearl","year":"1929","journal-title":"Am J Hyg"},{"key":"10.1016\/S1015-9584(08)60045-7_bib19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(69)92648-8","article-title":"Active immunotherapy for acute lymphoblastic leukaemia","volume":"1","author":"Mathe","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/S1015-9584(08)60045-7_bib20","first-page":"35","article-title":"History of BCG and its substrains","volume":"310","author":"Crispen","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/S1015-9584(08)60045-7_bib21","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/1097-0142(197410)34:8+<1532::AID-CNCR2820340827>3.0.CO;2-H","article-title":"Immunotherapy of guinea pig cancer with BCG","volume":"34","author":"Zbar","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/S1015-9584(08)60045-7_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavity Bacillus Calmette-Guerin in the treatment of superficial bladder tumours","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0022-5347(17)55282-9","article-title":"Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer","volume":"124","author":"Lamm","year":"1980","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0022-5347(01)66427-9","article-title":"Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomised study in patients with recurrent superficial bladder tumours","volume":"155","author":"Luftenegger","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-5347(17)46976-X","article-title":"Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results","volume":"134","author":"Kelley","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0302-2838(01)00026-4","article-title":"Guidelines on bladder cancer","volume":"41","author":"Oosterlink","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-5347(17)46972-2","article-title":"Bacillus Calmette-Guerin immunotherapy for bladder cancer","volume":"134","author":"Lamm","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0090-4295(99)00591-9","article-title":"Long-term results of intravesical bacillus Calmette-Guerin therapy for stage T1 superficial bladder cancer","volume":"55","author":"Brake","year":"2000","journal-title":"Urology"},{"key":"10.1016\/S1015-9584(08)60045-7_bib29","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of published results of randomised clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib30","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1200\/JCO.1988.6.9.1450","article-title":"Bacillus Calmette-Guerin therapy alters the progression of superficial bladder cancer","volume":"6","author":"Herr","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib31","article-title":"Intravesical bacillus Calmette-Guerin in Ta and T1 bladder cancer (Cochrane review)","author":"Shelley","year":"2004","journal-title":"The Cochrane Library"},{"key":"10.1016\/S1015-9584(08)60045-7_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1464-410X.2003.04357.x","article-title":"The management of stage T1 grade 3 transitional cell carcinoma of the bladder","volume":"92","author":"Evans","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/S1015-9584(08)60045-7_bib33","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1097\/01.ju.0000066840.42991.4a","article-title":"Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients","volume":"169","author":"Peyromaure","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib34","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-5347(05)67523-4","article-title":"Recurrence and progression of stage 1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin","volume":"163","author":"Brake","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0960-7404(02)00008-7","article-title":"BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer","volume":"11","author":"Bassi","year":"2002","journal-title":"Surg Oncol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib36","first-page":"499","article-title":"Carcinoma in situ","volume":"19","author":"Lamm","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1016\/S1015-9584(08)60045-7_bib37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0094-0143(21)00422-5","article-title":"Bacillus Calmette-Guerin immunotherapy. Techniques and results","volume":"19","author":"Brosman","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1016\/S1015-9584(08)60045-7_bib38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1464-410X.2003.04655.x","article-title":"Intravesical bacillus Calmette-Guerin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomised trials","volume":"93","author":"Shelley","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/S1015-9584(08)60045-7_bib39","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.1995.13.6.1404","article-title":"Intravesical bacillus Calmette-Guerin therapy prevents progression and death from superficial bladder cancer. Ten-year follow-up of a prospective randomized trial","volume":"13","author":"Herr","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib40","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized South West Oncology Group study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib41","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0022-5347(17)39546-0","article-title":"Long-term follow up of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumour","volume":"144","author":"Coplen","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib42","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-5347(17)45091-9","article-title":"Two courses of intravesi-cal bacillus Calmette-Guerin for transitional cell carcinoma of the bladder","volume":"136","author":"Haaff","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib43","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-5347(17)43959-0","article-title":"Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer","volume":"137","author":"Catalona","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005392-200102000-00011","article-title":"The ablative effect of quarter dose of bacillus Calmette-Guerin on a papillary marker lesion of bladder","volume":"165","author":"Mack","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-5347(17)37707-8","article-title":"A low dose bacillus Calmette-Guerin regimen in superficial bladder cancer: is it effective?","volume":"146","author":"Pagano","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0302-2838(03)00357-9","article-title":"Maintenance bacillus Calmette-Guerin for Ta, T1 bladder tumours is not associated with increased toxicity: results from a European Organisation for Research and treatment of Cancer Genito-Urinary Group Phase III Trial","volume":"44","author":"Van der Meijden","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0094-0143(21)00423-7","article-title":"Complications of bacillus Calmette-Guerin im-munotherapy","volume":"19","author":"Lamm","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1016\/S1015-9584(08)60045-7_bib48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-5347(17)43909-7","article-title":"Requirement of a thymus dependent immune response for BCG mediated antitumour activity","volume":"137","author":"Ratliff","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib49","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-5347(17)35678-1","article-title":"T-cell subsets required for intravesical BCG immunotherapy for bladder cancer","volume":"150","author":"Ratliff","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib50","first-page":"208","article-title":"Understanding the most successful immunotherapy for cancer","volume":"2","author":"Jackson","year":"1994","journal-title":"The Immunologist"},{"key":"10.1016\/S1015-9584(08)60045-7_bib51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s002400050039","article-title":"Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review","volume":"26","author":"Patard","year":"1998","journal-title":"Urol Res"},{"key":"10.1016\/S1015-9584(08)60045-7_bib52","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","article-title":"Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer","volume":"170","author":"Bohle","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib53","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0002-9610(02)00781-X","article-title":"Cytokines for surgeons","volume":"183","author":"Raeburn","year":"2002","journal-title":"Am J Surg"},{"key":"10.1016\/S1015-9584(08)60045-7_bib54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF01534428","article-title":"Induction of TH1 and TH2 associated cytokine mRNA in mouse bladder following intravesical growth of murine bladder tumor MB49 and BCG immunotherapy","volume":"39","author":"McAveney","year":"1994","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/S1015-9584(08)60045-7_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1043-4666(02)00490-8","article-title":"Role of Th1 and Th2 cytokines in BCG induced IFN-gamma production: cytokine promotion and simulation of BCG effect","volume":"21","author":"Luo","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/S1015-9584(08)60045-7_bib56","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0022-5347(05)64361-3","article-title":"Urinary interleukin-8 predicts the response of standard and low dose intravesical bacillus Calmette-Guerin (modified Danish 1331 strain) for superficial bladder cancer","volume":"168","author":"Kumar","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib57","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-5347(05)65469-9","article-title":"Prognostic value of a T helper 1 urinary cytokine response after intravesical bacillus Calmette-Guerin treatment for superficial bladder cancer","volume":"167","author":"Saint","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib58","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0022-5347(05)66983-2","article-title":"Urinary interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin","volume":"164","author":"Thalmann","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib59","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0022-5347(17)35941-4","article-title":"Dissecting the immuno-biological effects of bacillus Calmette-Guerin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon","volume":"150","author":"Bohle","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/S1015-9584(08)60045-7_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1078-1439(99)00015-0","article-title":"Intravesical chemotherapy and immunotherapy for superficial tumors: basic mechanism of action and future direction","volume":"4","author":"Akaza","year":"1998","journal-title":"Urol Oncol"}],"container-title":["Asian Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958408600457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958408600457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T17:17:40Z","timestamp":1760894260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1015958408600457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1015958408600457"],"URL":"https:\/\/doi.org\/10.1016\/s1015-9584(08)60045-7","relation":{},"ISSN":["1015-9584"],"issn-type":[{"value":"1015-9584","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacillus Calmette\u2013Gu\u00e9rin and Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1015-9584(08)60045-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Asian Surgical Association. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}